SCHEMBL3736965

SCHEMBL3736965

CC(N=CC(F)(F)F)c1cccc2ccccc12

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2C9 P11712 2/20 0.42
ALDH1A1 P00352 1/20 0.42
CYP1A2 P05177 1/20 0.42
CYP2C19 P33261 1/20 0.42
HDAC3 O15379 1/20 0.38
HDAC1 Q13547 1/20 0.38
HDAC6 Q9UBN7 1/20 0.38
ADRA2C P18825 6/20 0.37
CASR P41180 5/20 0.37
ADRA2A P08913 4/20 0.37
ADRA2B P18089 4/20 0.37
SLC6A4 P31645 3/20 0.37
ADRA1A P35348 2/20 0.37
SLC6A2 P23975 2/20 0.37
HTR2C P28335 2/20 0.37
OPRM1 P35372 2/20 0.37
DRD3 P35462 2/20 0.37
ADRA1B P35368 2/20 0.37
MLNR O43193 1/20 0.37
ABCB11 O95342 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3736958 1.00 CYP2C9 (0.42) CYP2C9ALDH1A1CYP1A2CYP2C19HDAC3
SCHEMBL3736960 1.00 CYP2C9 (0.42) CYP2C9ALDH1A1CYP1A2CYP2C19HDAC3
SCHEMBL29159451 0.89 ALDH1A1 (0.43) CYP2C9ALDH1A1CYP1A2CYP2C19ADRA2C
SCHEMBL20307886 0.80 ALDH1A1 (0.47) CYP2C9ALDH1A1CYP1A2CYP2C19ADRA2C
SCHEMBL12047423 0.75 ALDH1A1 (0.43) CYP2C9ALDH1A1CYP1A2CYP2C19ADRA2C
SCHEMBL20307892 0.75 ALDH1A1 (0.43) CYP2C9ALDH1A1CYP1A2CYP2C19ADRA2C
SCHEMBL6006538 0.75 ALDH1A1 (0.54) CYP2C9ALDH1A1CYP1A2CYP2C19ADRA2C
SCHEMBL25991088 0.72 ALDH1A1 (0.50) CYP2C9ALDH1A1CYP1A2CYP2C19ADRA2C
SCHEMBL3247325 0.72 ALDH1A1 (0.44) ALDH1A1ADRA2CADRA2ACYP2D6HTT
SCHEMBL5523449 0.71 CYP1A2 (0.46) CYP2C9ALDH1A1CYP1A2CYP2C19ADRA2C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100279936-A1 SUBSTITUTED ACETYLENIC COMPOUNDS USEFUL FOR THE TREATMENT OF DISEASES LEO PHARMA A/S (DK) 2010-11-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100279936-A1 SUBSTITUTED ACETYLENIC COMPOUNDS USEFUL FOR THE TREATMENT OF DISEASES C1R, C3AR1, PTH1R CYP2C9 361/4885ALDH1A1 1976/4885CYP1A2 1729/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.